Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection
- PMID: 11402001
- PMCID: PMC98534
- DOI: 10.1128/IAI.69.7.4572-4579.2001
Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection
Abstract
The vast majority of urinary tract infections are caused by strains of uropathogenic Escherichia coli that encode filamentous adhesive organelles called type 1 pili. These structures mediate both bacterial attachment to and invasion of bladder epithelial cells. However, the mechanism by which type 1 pilus-mediated bacterial invasion contributes to the pathogenesis of a urinary tract infection is unknown. Here we show that type 1-piliated uropathogens can invade the superficial epithelial cells that line the lumenal surface of the bladder and subsequently replicate, forming massive foci of intracellular E. coli termed bacterial factories. In response to infection, superficial bladder cells exfoliate and are removed with the flow of urine. To avoid clearance by exfoliation, intracellular uropathogens can reemerge and eventually establish a persistent, quiescent bacterial reservoir within the bladder mucosa that may serve as a source for recurrent acute infections. These observations suggest that urinary tract infections are more chronic and invasive than generally assumed.
Figures





Similar articles
-
Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses.Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):8829-35. doi: 10.1073/pnas.97.16.8829. Proc Natl Acad Sci U S A. 2000. PMID: 10922042 Free PMC article. Review.
-
A Murine Model for Escherichia coli Urinary Tract Infection.Methods Mol Biol. 2016;1333:159-75. doi: 10.1007/978-1-4939-2854-5_14. Methods Mol Biol. 2016. PMID: 26468108 Free PMC article.
-
Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.Immunobiology. 2011 Nov;216(11):1164-71. doi: 10.1016/j.imbio.2011.05.011. Epub 2011 May 24. Immunobiology. 2011. PMID: 21802164
-
Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis.J Infect Dis. 2015 Apr 1;211(7):1164-73. doi: 10.1093/infdis/jiu577. Epub 2014 Oct 21. J Infect Dis. 2015. PMID: 25336727 Free PMC article.
-
Dynamic interactions between host and pathogen during acute urinary tract infections.Urology. 2001 Jun;57(6 Suppl 1):56-61. doi: 10.1016/s0090-4295(01)01130-x. Urology. 2001. PMID: 11378051 Review.
Cited by
-
Intrauterine growth restriction is a direct consequence of localized maternal uropathogenic Escherichia coli cystitis.PLoS One. 2012;7(3):e33897. doi: 10.1371/journal.pone.0033897. Epub 2012 Mar 21. PLoS One. 2012. PMID: 22470490 Free PMC article.
-
Phenotypic and genotypic characteristics of Escherichia coli strains isolated during a longitudinal follow-up study of chronic urinary tract infections.Front Public Health. 2023 Nov 22;11:1240392. doi: 10.3389/fpubh.2023.1240392. eCollection 2023. Front Public Health. 2023. PMID: 38074750 Free PMC article.
-
The siderophore yersiniabactin binds copper to protect pathogens during infection.Nat Chem Biol. 2012 Aug;8(8):731-6. doi: 10.1038/nchembio.1020. Epub 2012 Jul 8. Nat Chem Biol. 2012. PMID: 22772152 Free PMC article.
-
The arsenal of pathogens and antivirulence therapeutic strategies for disarming them.Drug Des Devel Ther. 2016 May 27;10:1795-806. doi: 10.2147/DDDT.S98939. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27313446 Free PMC article. Review.
-
Rapid Bladder Interleukin-10 Synthesis in Response to Uropathogenic Escherichia coli Is Part of a Defense Strategy Triggered by the Major Bacterial Flagellar Filament FliC and Contingent on TLR5.mSphere. 2019 Nov 27;4(6):e00545-19. doi: 10.1128/mSphere.00545-19. mSphere. 2019. PMID: 31776239 Free PMC article.
References
-
- Barza M. Urinary tract. In: Schaeter M, Engelberg N C, Eisenstein B I, Medoff G, editors. Mechanisms of microbial disease. Philadelphia, Pa: Williams & Wilkins; 1998. pp. 564–572.
-
- Blattner F R, Plunkett III G, Bloch C A, Perna N T, Burland V, Riley M, Collado-Vides J, Glasner J D, Rode C K, Mayhew G F, Gregor J, Davis N W, Kirkpatrick H A, Goeden M A, Rose D J, Mau B, Shao Y. The complete genome sequence of Escherichia coli K-12. Science. 1997;277:1453–1474. - PubMed
-
- Blomfield I C, McClain M S, Eisenstein B I. Type 1 fimbriae mutants of Escherichia coli K12: characterization of recognized afimbriate strains and construction of new fim deletion mutants. Mol Microbiol. 1991;5:1439–1445. - PubMed
-
- Brauner A, Jacobson S H, Kuhn I. Urinary Escherichia coli causing recurrent infections–a prospective follow-up of biochemical phenotypes. Clin Nephrol. 1992;38:318–323. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical